Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06538311
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
Transcranial Magnetic Stimulation Treatment for Alzheimers Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Neuromodulation of Brain Function in Alzheimers Disease and Related Dementias
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this research study we want to learn more about the effects of non-invasive brain stimulation on memory and brain-network function in cognitively unimpaired older adults and in patients with amnestic mild cognitive impairment aMCI
This study will use a form of non-invasive brain stimulation called repetitive Transcranial Magnetic Stimulation rTMS rTMS will slightly alter activity in an area of your brain that controls memory Changes resulting from this stimulation will be measured with behavioral tests of memory and general cognition as well as by taking images of your brain with Magnetic Resonance Imaging MRI
Participants will come in for one baseline visit followed by 10 days of daily rTMS study visits Monday through Friday and an evaluation visit Then there will be a 2-week break After this break they will return for another baseline visit an additional 10 days of rTMS and a final evaluation visit
This study will use a form of non-invasive brain stimulation called repetitive Transcranial Magnetic Stimulation rTMS rTMS will slightly alter activity in an area of your brain that controls memory Changes resulting from this stimulation will be measured with behavioral tests of memory and general cognition as well as by taking images of your brain with Magnetic Resonance Imaging MRI
Participants will come in for one baseline visit followed by 10 days of daily rTMS study visits Monday through Friday and an evaluation visit Then there will be a 2-week break After this break they will return for another baseline visit an additional 10 days of rTMS and a final evaluation visit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None